abstract
OBJECTIVES:
To
determine the prevalence of sexual dysfunction in women after
risk-reducing salpingo-oophorectomy (RRSO) and to assess factors which
may influence sexual wellbeing following this procedure.
METHODS:
This
work is a cross-sectional study of women who underwent RRSO at a
tertiary gynecologic oncology unit between January 2009 and October
2014. Data collection involved a comprehensive questionnaire including
validated measures of sexual function, sexual distress, relationship
satisfaction, body image, impact of event, menopause specific quality of
life, and general quality of life. Participants were invited to undergo
blood testing for serum testosterone and free androgen index (FAI).
RESULTS:
119
of the 206 eligible women participated (58%), with a mean age of
52years. The prevalence of female sexual dysfunction (FSD) was 74% and
the prevalence of hypoactive sexual desire disorder (HSDD) was 73%.
Common sexual issues experienced included; lubrication difficulty (44%),
reduced sexual satisfaction (41%), dyspareunia (28%) and orgasm
difficulty (25%). Relationship satisfaction, the use of topical vaginal
estrogen and lower generalized body pain were significantly associated
with a decreased likelihood of sexual dysfunction. Serum testosterone,
FAI, the use of systemic hormone replacement therapy (HRT), prior
history of breast cancer, menopausal status at the time of surgery and
hysterectomy did not correlate with sexual dysfunction.
CONCLUSION:
The
prevalence of FSD and HSDD after RRSO was 74% and 73% respectively.
Relationship satisfaction, low bodily pain and use of topical vaginal
estrogen were associated with a lower likelihood of sexual dysfunction.
There was no correlation between serum testosterone or FAI, and sexual
dysfunction.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.